The induction of cardiac ornithine decarboxylase by β2- adrenergic agents is associated with calcium channels and phosphorylation of ERK1/2

Journal of Cellular Biochemistry

Volumn 114, Issue 9, 2013, Pages 1978-1986

  Lõpez Contreras, Andrés J ^a   De La Morena, Maria Eugenia ^a   Ramos Molina, Bruno ^a   Lambertos, Ana ^a   Cremades, Asunciõn ^a   Peñafiel, Rafael ^a  

^a UNIVERSITY OF MURCIA   (Spain)

Author keywords

Beta Adrenergic Agents; CREB; L Calcium Channels; Map Kinases; Ornithine Decarboxylase; Polyamines

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; CLENBUTEROL; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DOBUTAMINE; FENOTEROL; ISOPRENALINE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NIFEDIPINE; ORNITHINE DECARBOXYLASE; PROTEIN C FOS; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME PHOSPHORYLATION; HEART HYPERTROPHY; MALE; MOUSE; NONHUMAN; ONCOGENE C FOS; ONCOGENE C MYC; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

MUS;

EID: 84881391182     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24540     Document Type: Article

References (59)

1. Abrahamsen MS, Li RS, Dietrich-Goetz W, Morris DR,. 1992. Multiple DNA elements responsible for transcriptional regulation of the ornithine decarboxylase gene by protein kinase A. J Biol Chem 267: 18866-18873.
2. Adams JW, Sakata Y, Davis MG, Sah VP, Wang Y, Liggett SB, Chien KR, Brown JH, Dorn GW,. 1998. Enhanced Galphaq signaling: A common pathway mediates cardiac hypertrophy and apoptotic heart failure. Proc Natl Acad Sci USA 95: 10140-10145.
3. Bartolome J, Huguenard J, Slotkin T,. 1980. A role of ornithine decarboxylase in cardiac growth and hypertrophy. Science 210: 793-794.
4. Bartolome JV, Trepanier PA, Chait EA, Slotkin TA,. 1982. Role of polyamines in isoproterenol-induced cardiac hypertrophy: Effects of alpha-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase. J Mol Cell Cardiol 14: 461-466.
5. Bastida CM, Cremades A, Castells MT, Lopez-Contreras JA, Lopez-García C, Tejada F, Penafiel R,. 2005. Influence of ovarian ornithine decarboxylase in folliculogenesis and luteinization. Endocrinology 146: 666-674.
6. Bello-Fernandez C, Packham G, Cleveland JL,. 1993. The ornithine decarboxylase gene is a transcriptional target of c-Myc. Proc Natl Acad Sci USA 90: 7804-7808.
7. Bishopric NH, Sato B, Webster KA,. 1992. Beta-adrenergic regulation of a myocardial actin gene via a cyclic AMP-independent pathway. J Biol Chem 267: 20932-20936.
8. Bogoyevitch MA, Andersson MB, Gillespie-Brown J, Clerk A, Glennon PE, Fuller SJ, Sudgen PH,. 1996. Adrenergic receptor stimulation on the mitogen-activated protein kinase cascade and cardiac hypertrophy. Biochem J 314: 115-121.
9. Bordallo C, Cantabrana B, Velasco L, Secades L, Meana C, Mendez M, Bordallo J, Sanchez M,. 2008. Putrescine modulation of acute activation of the beta-adrenergic system in the left atrium of rat. Eur J Pharmacol 598: 68-74.
10. Bordallo C, Rubin JM, Varona AB, Cantabrana B, Hidalgo A, Sanchez M,. 2001. Increases in ornithine decarboxylase activity in the positive inotropism induced by androgens in isolated left atrium of the rat. Eur J Pharmacol 422: 101-107.
11. Coffino P,. 2001. Regulation of cellular polyamines by antizyme. Nat Rev Mol Cell Biol 2: 188-194.
12. Cohen SS,. 1998. A guide to the polyamines. New York: Oxford University Press.
13. Copeland JG, Larson DF, Roeske WR, Russell DH, Womble JR,. 1982. Beta 2-Adrenoceptors regulate induction of myocardial ornithine decarboxylase in mice in vivo. Br J Pharmacol 75: 479-483.
14. Cubria JC, Ordonez C, Reguera RM, Tekwani BL, Balana-Fouce R, Ordonez D,. 1999. Early alterations of polyamine metabolism induced after acute administration of clenbuterol in mouse heart. Life Sci 64: 1739-1752.
15. Daaka Y, Luttrell LM, Lefkowitz RJ,. 1997. Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A. Nature 390: 88-91.
16. Fan CC, Koening H,. 1998. The role of polyamines in β-adrenergic stimulation of calcium influx and membrane transport in rat heart. J Mol Cell Cardiol 20: 789-799.
17. Faure M, Voyno-Yasenetskaya TA, Bourne HR,. 1994. cAMP and beta gamma subunits of heterotrimeric G proteins stimulate the mitogen-activated protein kinase pathway in COS-7 cells. J Biol Chem 269: 7851-7854.
18. + channels. Science 266: 1068-1072.
19. Fischmeister R, Castro LR, Abi-Gerges A, Rochais F, Jurevicius J, Leroy J, Vandecasteele G,. 2006. Compartmentation of cyclic nucleotide signaling in the heart: The role of cyclic nucleotide phosphodiesterases. Circ Res 99: 816-828.
20. Flamigni F, Rossoni C, Stefanelli C, Caldarera CM,. 1986. Polyamine metabolism and function in the heart. J Mol Cell Cardiol 18: 3-11.
21. Fujita K, Murakami Y, Hayashi S,. 1982. A macromolecular inhibitor of the antizyme to ornithine decarboxylase. Biochem J 204: 647-652.
22. Gan XT, Rajapurohitam V, Haist JV, Chidiac P, Cook MA, Karmazyn M,. 2005. Inhibition of phenylephrine-induced cardiomyocyte hypertrophy by activation of multiple adenosine receptor subtypes. J Pharmacol Exp Ther 312: 27-34.
23. Gao T, Puri TS, Gerhardstein BL, Chien AJ, Green RD, Hosey MM,. 1997. Identification and subcellular localization of the subunits of L-type calcium channels and adenylyl cyclase in cardiac myocytes. J Biol Chem 272: 19401-19407.
24. Giordano E, Hillary AR, Vary TC, Pegg AE, Sumner AD, Caldarera CM, Zhang X, Song J, Wang J, Cheung JY, Shantz LM,. 2012. Overexpression of ornithine decarboxylase decreases ventricular systolic function during induction of cardiac hypertrophy. Amino Acids 42: 507-518.
25. Guarnieri C, Flamigni F, Muscari C, Caldarera CM,. 1983. Involvement of calcium ions in the activation of ornithine decarboxylase by isoprenaline evaluated "in situ" in the perfused rat heart. Biochem J 212: 241-243.
26. 2+ sensitivity of tension and increase rates of activation in skinned cardiac myocytes. Am J Physiol Heart Circ Physiol 279: H1383-H1391.
27. He Q, Harding P, LaPointe MC,. 2010. PKA Rap1, ERK1/2, and p90RSK mediate PGE2 and EP4 signaling in neonatal ventricular myocytes. Am J Physiol Heart Circ Physiol 298: H136-H143.
28. Houslay MD, Kolch W,. 2000. Cell-type specific integration of cross-talk between extracellular signal-regulated kinase and cAMP signaling. Mol Pharmacol 58: 659-668.
29. Kahana C,. 2009. Antizyme and antizyme inhibitor, a regulatory tango. Cell Mol Life Sci 66: 2479-2488.
30. Kaumann AJ,. 1997. Four beta-adrenoceptor subtypes in the mammalian heart. Trends Pharmacol Sci 18: 70-76.
31. 2+)i and membrane transport in rat heart myocytes. Biochem Biophys Res Commun 153: 1179-1185.
32. Lau C, Slotkin TA,. 1982. Stimulation of rat heart ornithine decarboxylase by isoproterenol evidence for post-translational control of enzyme activity ? Eur J Pharmacol 78: 99-105.
33. Lopatin AN, Makhina EN, Nichols CG,. 1994. Potassium channel block by cytoplasmic polyamines as the mechanism of intrinsic rectification. Nature 372: 366-369.
34. Lõpez-Contreras AJ, Ramos-Molina B, Cremades A, Peñafiel R,. 2010. Antizyme inhibitor 2: Molecular, cellular and physiological aspects. Amino Acids 38: 603-611.
35. Mackintosh CA, Feith DJ, Shantz LM, Pegg AE,. 2000. Overexpression of antizyme in the hearts of transgenic mice prevents the isoprenaline-induced increase in cardiac ornithine decarboxylase activity and polyamines, but does not prevent cardiac hypertrophy. Biochem J 350: 645-653.
36. Mangold U,. 2006. Antizyme inhibitor: Mysterious modulator of cell proliferation. Cell Mol Life Sci 63: 2095-2101.
37. Manna PR, Stocco DC,. 2007. Crosstalk of CREB and Fos/Jun on a single cis-element: Transcriptional repression of the steroidogenic acute regulatory protein gene. J Mol Endocrinol 39: 261-267.
38. Packham G, Cleveland JL,. 1997. Induction of ornithine decarboxylase by IL-3 is mediated by sequential c-Myc-independent and c-Myc-dependent pathways. Oncogene 15: 1219-1232.
39. Palvimo JJ, Eisenberg LM, Janne OA,. 1991. Protein-DNA interactions in the cAMP responsive promoter region of the murine ornithine decarboxylase gene. Nucleic Acids Res 19: 3921-3927.
40. Pegg AE,. 1981. Effect of alpha-difluoromethylornithine on cardiac polyamine content and hypertrophy. J Mol Cell Cardiol 13: 881-887.
41. Pegg AE,. 2006. Regulation of ornithine decarboxylase. J Biol Chem 281: 14529-14532.
42. Pegg AE,. 2009. Mammalian polyamine metabolism and function. IUBMB Life 61: 880-894.
43. Ramos-Molina B, Lõpez-Contreras AJ, Cremades A, Peñafiel R,. 2012. Differential expression of ornithine decarboxylase antizyme inhibitors and antizymes in rodent tissues. Amino Acids 42: 539-547.
44. Robbins RJ, Swain JL,. 1992. C-mycprotooncogene modulates cardiac hypertrophyc growth in transgenic mice. Am J Physiol 262: H590-H597.
45. Rockman HA, Koch WJ, Lefkowitz RJ,. 2002. Seven-transmembrane-spanning receptors and heart function. Nature 415: 206-212.
46. Sands WA, Palmer TM,. 2008. Regulating gene transcription in response to cyclic AMP elevation. Cell Signal 20: 460-466.
47. Schluter KD, Frischkopf K, Flesch M, Rosenkranz S, Taimor G, Piper HM,. 2000. Central role for ornithine decarboxylase in beta-adrenoceptor mediated hypertrophy. Cardiovasc Res 45: 410-417.
48. Shantz LM, Feith DJ, Pegg AE,. 2001. Targeted overexpression of ornithine decarboxylase enhances beta-adrenergic agonist-induced cardiac hypertrophy. Biochem J 358: 25-32.
49. Shimizu M, Irimajiri O, Nakano T, Mizokami T, Ogawa K, Sanjo J, Yamada H, Sasaki H, Isogai Y,. 1991. Effect of captopril on isoproterenol-induced myocardial ornithine decarboxylase activity. J Mol Cell Cardiol 23: 665-670.
50. Steinberg SF,. 1999. The molecular basis for distinct beta-adrenergic receptor subtype actions in cardiomyocytes. Circ Res 85: 1101-1111.
51. Thomas T, Thomas TJ,. 2001. Polyamines in cell growth and cell death: Molecular mechanisms and therapeutic applications. Cell Mol Life Sci 58: 244-258.
52. Tipnis UR, Frasier-Scott K, Skiera C,. 1989. Isoprenaline induced changes in ornithine decarboxylase activity and polyamine content in regions of the rat heart. Cardiovasc Res 23: 611-619.
53. Tovar A, Sanchez-Capelo A, Cremades A, Penafiel R,. 1995. An evaluation of the role of polyamines in different models of kidney hypertrophy in mice. Kidney Int 48: 731-737.
54. Warnica JW, Antony P, Gibson K, Harris P,. 1975. The effect of isoprenaline and propranolol on rat myocardial ornithine decarboxylase. Cardiovasc Res 9: 793-796.
55. Xiang Y, Kobilka BK,. 2003. Myocyte adrenoceptor signaling pathways. Science 300: 1530-1532.
56. 2-adrenergic signal transduction. Circ Res 85: 1092-1100.
57. Zheng M, Han QD, Xiao RP,. 2004. Distinct β-adrenergic receptor subtype signaling in the heart and their pathophysiological relevance. Acta Physiol Sin 25: 1-15.
58. Zhou YY, Cheng H, Bogdanov KY, Hohl C, Altschuld R, Lakatta EG, Xiao RP,. 1997. Localized cAMP-dependent signaling mediates beta 2-adrenergic modulation of cardiac excitation-contraction coupling. Am J Physiol 273: H1611-H1618.
59. Zou Y, Komuro I, Yamazaki T, Kudoh S, Uozumi H, Kadowaki T, Yazaki Y,. 1999. Both Gs and Gi proteins are critically involved in isoproterenol-induced cardiomyocyte hypertrophy. J Biol Chem 274: 9760-9770.